Your browser doesn't support javascript.
loading
Plain language summary of zanubrutinib or ibrutinib in chronic lymphocytic leukemia that is resistant to treatment or has come back after treatment.
Brown, Jennifer R; Eichhorst, Barbara; Hillmen, Peter; Jurczak, Wojciech; Kazmierczak, Maciej; Lamanna, Nicole; O'Brien, Susan M; Tam, Constantine S; Qiu, Lugui; Zhou, Keshu; Simkovic, Martin; Mayer, Jiri; Gillespie-Twardy, Amanda; Ferrajoli, Alessandra; Ganly, Peter S; Weinkove, Robert; Grosicki, Sebastian; Mital, Andrzej; Robak, Tadeusz; Osterborg, Anders; Yimer, Habte A; Salmi, Tommi; Wang, Megan-Der-Yu; Fu, Lina; Li, Jessica; Wu, Kenneth; Cohen, Aileen; Shadman, Mazyar.
Afiliação
  • Brown JR; The Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
  • Eichhorst B; The Department of Internal Medicine, University of Cologne, Center for Integrated Oncology Aachen Bonn Köln Düsseldorf, Cologne, Germany.
  • Hillmen P; St. James's University Hospital, Leeds, United Kingdom.
  • Jurczak W; Maria Sklodowska-Curie National Research Institute of Oncology, Krakow, Poland.
  • Kazmierczak M; The Department of Hematology & Bone Marrow Transplantation, Poznan University of Medical Sciences, Poznan, Poland.
  • Lamanna N; Herbert Irving Comprehensive Cancer Center, Columbia University, New York, New York, USA.
  • O'Brien SM; Chao Family Comprehensive Cancer Center, University of California, Irvine, California, USA.
  • Tam CS; The Alfred Hospital & Monash University, Melbourne, VIC, Australia.
  • Qiu L; The State Key Laboratory of Experimental Hematology, National Clinical Medical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China.
  • Zhou K; The Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou, China.
  • Simkovic M; The Fourth Department of Internal Medicine-Hematology, University Hospital, Hradec Kralove, Czech Republic, & The First Faculty of Medicine, Charles University, Prague, & the Department of Internal Medicine, Prague, Czech Republic.
  • Mayer J; Hematology & Oncology, Masaryk University & University Hospital, Brno, Czech Republic.
  • Gillespie-Twardy A; Blue Ridge Cancer Care, Roanoke, Virginia, USA.
  • Ferrajoli A; The Leukemia Department, University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA.
  • Ganly PS; The Department of Haematology, Christchurch Hospital, Christchurch, New Zealand.
  • Weinkove R; Te Rerenga Ora Blood & Cancer Centre, Te Whatu Ora Health New Zealand Capital Coast & Hutt Valley, & the Cancer Immunotherapy Programme, Malaghan Institute of Medical Research, Wellington, New Zealand.
  • Grosicki S; The Department of Hematology & Cancer Prevention, Faculty of Health Sciences, Medical University of Silesia, Katowice, Poland.
  • Mital A; The Department of Hematology & Transplantology, Medical University of Gdansk, Gdansk, Poland.
  • Robak T; The Medical University of Lodz, Lodz, Poland.
  • Osterborg A; The Department of Oncology-Pathology, Karolinska Institutet, Stockholm & the Department of Hematology, Karolinska University Hospital, Stockholm, Sweden.
  • Yimer HA; Texas Oncology-Tyler, US Oncology Network, Tyler, Texas, USA.
  • Salmi T; BeiGene International GmbH, Basel, Switzerland.
  • Wang MD; BeiGene USA, San Mateo, California, USA.
  • Fu L; Formerly of BeiGene.
  • Li J; BeiGene (Beijing), Beijing, China.
  • Wu K; BeiGene USA, San Mateo, California, USA.
  • Cohen A; BeiGene USA, San Mateo, California, USA.
  • Shadman M; The Fred Hutchinson Cancer Center & the Department of Medicine, University of Washington, Seattle, USA.
Future Oncol ; 20(12): 717-726, 2024 Apr.
Article em En | MEDLINE | ID: mdl-38088119

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pirimidinas / Adenina / Leucemia Linfocítica Crônica de Células B / Linfoma de Células B Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pirimidinas / Adenina / Leucemia Linfocítica Crônica de Células B / Linfoma de Células B Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article